76 related articles for article (PubMed ID: 15841772)
1. Pheochromocytoma in childhood: implication for further diagnostic procedures.
Beck O; Fassbender WJ; Beyer P; Kriener S; Neumann HP; Klingebiel T; Lehrnbecher T
Acta Paediatr; 2004 Dec; 93(12):1630-4. PubMed ID: 15841772
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
3. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?
Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ
Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926
[TBL] [Abstract][Full Text] [Related]
4. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
[TBL] [Abstract][Full Text] [Related]
5. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: report of a case and a review of the Japanese literature.
Oishi S; Sasaki M; Sato T; Isogai M
Jpn J Clin Oncol; 1995 Aug; 25(4):153-8. PubMed ID: 7666591
[TBL] [Abstract][Full Text] [Related]
8. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
Pati M; Sperti P; Magiar AV; Bonifacio V
Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient.
Sarathi V; Bandgar TR; Menon PS; Shah NS
Gynecol Endocrinol; 2011 Aug; 27(8):533-5. PubMed ID: 20672905
[TBL] [Abstract][Full Text] [Related]
10. No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma.
Montani M; Schmitt AM; Schmid S; Locher T; Saremaslani P; Heitz PU; Komminoth P; Perren A
Endocr Relat Cancer; 2005 Dec; 12(4):1011-6. PubMed ID: 16322339
[TBL] [Abstract][Full Text] [Related]
11. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
12. Simultaneously occurring liver metastases of pheochromocytoma and medullary thyroid carcinoma--a diagnostic pitfall with clinical implications for patients with multiple endocrine neoplasia type 2a.
Hinze R; Machens A; Schneider U; Holzhausen HJ; Dralle H; Rath FW
Pathol Res Pract; 2000; 196(7):477-81. PubMed ID: 10926325
[TBL] [Abstract][Full Text] [Related]
13. Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.
Pomorski L; Bartkowiak J; Pisarek H; Bartos M; Narebski J
Neoplasma; 2000; 47(5):323-6. PubMed ID: 11130252
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 2.
Wohllk N; Schweizer H; Erlic Z; Schmid KW; Walz MK; Raue F; Neumann HP
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):371-87. PubMed ID: 20833330
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2].
Kuznetsov NS; Bel'tsevich DG; Poliakova EIu; Vasil'ev EV; Nemtsova MV
Khirurgiia (Mosk); 2002; (2):4-9. PubMed ID: 12418313
[TBL] [Abstract][Full Text] [Related]
16. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
[TBL] [Abstract][Full Text] [Related]
17. [Multiple endocrine neoplasia type 2b. Clinical, diagnostic and therapeutic aspects].
Gardet P; Rougier P; Navarro J; Schlumberger M; Travagli JP; Caillou B; Hartmann O; Lemerle J; Parmentier C
Bull Cancer; 1984; 71(3):172-81. PubMed ID: 6148975
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytoma in multiple endocrine neoplasia type II: an example of the two-hit theory of neoplasia.
Cerny JC; Jackson CE; Talpos GB; Yott JB; Lee MW
Surgery; 1982 Nov; 92(5):849-52. PubMed ID: 6127813
[TBL] [Abstract][Full Text] [Related]
19. [Histology and puncture cytology of malignant tumors of the thyroid gland in childhood and adolescence].
Emmrich P; Willgerodt H; Keller E; Bennek J; Fuchs U
Pathologe; 1993 Dec; 14(6):318-24. PubMed ID: 7907180
[No Abstract] [Full Text] [Related]
20. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
